20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo
Open Access
- 12 July 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 46 (3), 396-407
- https://doi.org/10.1016/j.jgr.2021.07.004
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education (2020R1A4A1018280)
This publication has 61 references indexed in Scilit:
- The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspectiveCancer Management and Research, 2013
- Regulatory networks defining EMT during cancer initiation and progressionNature Reviews Cancer, 2013
- An overview of colorectal cancer survival rates and prognosis in AsiaWorld Journal of Gastrointestinal Oncology, 2012
- A dynamic study on reversal of multidrug resistance by ginsenoside Rh2 in adriamycin-resistant human breast cancer MCF-7 cellsTalanta, 2011
- Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53Cancer Letters, 2011
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancerOncogene, 2010
- Estrogen rapid action via protein complex formation involving ERα and SrcTrends in Endocrinology & Metabolism, 2005
- Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyLeukemia, 2003
- The Gas6/Axl SystemTrends in Cardiovascular Medicine, 1999